Rubicon Research Ltd share price logo

Rubicon Research Ltd

NSE: RUBICON

BSE: 544578

Small Cap

Pharma Sector

₹1776.70

-38.90

(-2.14%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Rubicon Research shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+83%

Searches for Rubicon Research on INDmoney have increased by 83% over the last 30 days.

Investment activity on INDmoney

+194.32%

Investment activity in Rubicon Research among INDmoney users has increased by 194.32% over the last 30 days.

Among the most traded stocks

299th

Rubicon Research was the 299th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

8 days

INDmoney investors hold Rubicon Research shares for an average of 8 days.

Key Events for Rubicon Research

Last Dividend Declared

₹1.50 per share, declared on 29/05/2026

View Dividend History

Rubicon Research Stock Performance

as on September 16, 2026 at 8:32 pm IST

  • Day's Low

    Day's High

    ₹1,712.10
    ₹1,812.30
    downward going graph

    3.64%

    Downside

    2.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹570.75
    ₹1,899.00
    downward going graph

    67.88%

    Downside

    6.88%

    Upside

    downward going graph

Rubicon Research share price movements today

Previous Close
₹1,815.60
Open
₹1,776.20
Volume
3.78L
Upper Circuit
₹2,178.70
Lower Circuit
₹1,452.50
Day's Low - High
₹1,712.10 - ₹1,812.30
52 Week Low - High
₹570.75 - ₹1,899.00

Rubicon Research Historical Returns

1 Month Return
+ 0.94 %
3 Month Return
+ 34.33 %
1 Year Return
+ 189.02 %
3 Year Return
+ 189.02 %
5 Year Return
+ 189.02 %

Rubicon Research Fundamentals

as on September 16, 2026 at 3:02 pm IST

Market Cap

₹30,053.97 Cr

Return on Equity (ROE)

18.62

PE Ratio (TTM)

103.34

Return on capital employed (ROCE)

20.82

Industry PE ratio

51.81

Beta (LTM)

0.32

P/B Ratio

9.42

Dividend Yield

0.19

PEG Ratio

13.23

Quarterly Earnings Growth YOY

95.8

EPS (TTM)

14.95

Book Value

78.07

Rubicon Research Stock Valuation

as on September 16, 2026 at 3:02 pm IST

Rubicon Research in the last 5 years

  • Overview

  • Trends

Lowest (49.51x)

January 23, 2026

Industry (51.81x)

September 11, 2026

Today (103.34x)

September 11, 2026

Highest (104.76x)

September 8, 2026

LowHigh

Today’s Price to Earnings Ratio: 103.34x

Rubicon Research Technical Analysis

Track how Rubicon Research technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish9
Bullish3
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-4.2
Bullish
CCI (20)
-94.04
Neutral
RSI (14)
42.78
Neutral
Momentum (10)
-0.2
Bullish
ADI (14)
47.81
Bearish
Ultimate Oscillator (7,14,28)
58.28
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1773.43
Bearish
EMA (20)
1773.61
Bearish
VWMA (20)
1770.8
Bullish
SMA (50)
1783.44
Bearish
EMA (50)
1779.76
Bearish
SMA (200)
1781.63
Bearish
EMA (200)
1780.17
Bearish
KAMA (200)
1772.99
Bearish
DEMA (200)
1781.87
Bearish

Rubicon Research Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rubicon Research with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Rubicon Research Ltd image
Rubicon Research Ltd
BUY30,053.9737.8%0.602461,753
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Market expectation of Rubicon Research Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Rubicon Research Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
316.72
296.01
313.4
358.15
352.49
412.02
475.53
513.92
534.34
Other Income
0.39
2.66
0.49
0.1
0.63
0.7
3.79
2.61
5.68
Total Income
317.1
298.67
313.89
358.25
353.13
412.72
479.32
516.53
540.02
Expenses
256.49
234.35
243.5
285.67
273.38
317.72
367.4
395.21
405.22
Operating Profit
60.23
61.66
69.9
72.48
79.11
94.3
108.13
118.71
129.12
Operating Profit Margin %
19.02%
20.83%
22.3%
20.24%
22.44%
22.89%
22.74%
23.1%
24.16%
Profit Before Interest, Tax and Depreciation
60.61
64.32
70.39
72.57
79.74
94.99
111.91
121.31
134.8
Interest
10.09
7.02
7.82
11.85
10.62
11.42
9.77
10.36
9.29
Depreciation
9.36
8.15
9.42
9.66
9.57
11.87
11.55
12.27
15.14
Profit Before Tax
41.16
49.15
53.15
51.06
59.55
71.7
90.59
98.68
110.37
Tax Paid
15.6
14.68
15.08
14.81
16.25
17.85
17.79
21.9
25.59
Profit After Tax
25.57
34.48
38.07
36.25
43.3
53.85
72.8
76.79
84.78
Total Net profit including share of profit / Loss from associate company
25.57
34.48
38.07
36.25
43.3
53.85
72.8
76.79
84.78
EPS
1.66
2.27
2.5
2.37
2.81
3.49
4.46
4.68
5.13
Actual EPS
1.66
2.27
2.5
2.37
2.81
3.49
4.46
4.68
5.13
Adjusted EPS
1.66
2.27
2.5
2.37
2.81
3.49
4.46
4.68
5.13
Diluted EPS
-
2.23
2.46
2.34
2.79
3.47
4.41
4.6
5.08

Rubicon Research Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
313.57
393.52
853.89
1,284.27
1,753.96
Other Income
16.85
25.48
18.5
3.63
7.73
Total Income
330.42
419
872.39
1,287.91
1,761.68
Expenses
352.8
375.03
699.3
1,020.01
1,353.72
Operating Profit
-39.23
18.49
154.59
264.26
400.24
Operating Profit Margin %
-12.51%
4.7%
18.1%
20.58%
22.82%
Profit Before Interest, Tax and Depreciation
-22.38
43.97
173.09
267.89
407.96
Interest
9.72
18.96
31.26
36.78
42.17
Depreciation
34.01
36.06
38.97
36.59
45.26
Profit Before Tax
-66.11
-11.05
102.86
194.52
320.53
Tax Paid
1.01
5.84
11.85
60.16
73.8
Profit After Tax
-67.12
-16.89
91.01
134.36
246.74
Total Net profit including share of profit / Loss from associate company
-67.12
-16.89
91.01
134.36
246.74
EPS
-4.41
-1.11
5.98
8.82
15.52
Actual EPS
-4.41
-1.11
5.98
8.82
15.52
Adjusted EPS
-0.15
-0.04
5.98
8.82
15.52
Diluted EPS
-4.41
-1.11
5.91
8.68
15.31

Rubicon Research Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
5.47
61.67
-62.63
-74.75
21.01
159.18
205.05
Cash Flow from Investing Activities
-25.29
25.2
8.59
12.16
-12.24
-65
-407.43
Cash Flow from Financing Activities
80.07
51.5
63.04
122.82
43.55
-39.8
283.06
Net Cash Flow
1.21
67.08
-45.49
15.76
-3.82
54.37
80.68

Rubicon Research Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2025
Oct 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
84.15%
59.99%
59.99%
59.99%
59.86%
59.76%
DII
0%
10.54%
10.54%
9.45%
10.02%
9.43%
FII
0%
9.37%
9.37%
8%
7.54%
7.52%
Public
0%
20.1%
20.1%
22.57%
22.58%
23.3%
Total Outstanding Shares
15,20,99,340
16,47,50,309
16,47,50,309
16,47,50,309
16,50,92,124
16,53,82,750
Total Shareholders
15
1,05,311
1,05,311
31,914
33,738
43,254

Rubicon Research Corporate Actions

View detailed summary of the earnings and dividend history of Rubicon Research.

  • Rubicon Research Ltd Earnings Results

    Rubicon Research Ltd’s net profit jumped 95.8% since last year same period to ₹84.78Cr in the Q1 2026-2027. On a quarterly growth basis, Rubicon Research Ltd has generated 10.41% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Rubicon Research Ltd Dividends May,2026

    In the quarter ending March 2026, Rubicon Research Ltd has declared dividend of ₹1.50 per share on 29 May 2026 - translating a dividend yield of 0.08%.

    Read More about Dividends

Indices Featuring Rubicon Research Stock

Check stock indices that include Rubicon Research.

BSE Healthcare

₹50,354.85

-123.96 (▲0.25%)

BSE IPO

₹18,206.74

-169.40 (▲0.92%)

Insights on Rubicon Research Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.14% to 7.23% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RUBICON stock has moved up by 34.3%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 22.58% to 23.30% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 59.86% to 59.76% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.54% to 7.52% in Jun 2026 quarter

About Rubicon Research Ltd

Rubicon Research Limited was incorporated on May 6 1999 as a Private Limited Company under the name Rubicon Consultants Private Limited issued by the RoC. Subsequently the Company name was changed from Rubicon Consultants Private Limited to RubiconResearch Private Limited consequent to which a fresh Certificate of Incorporation was issued by the RoC dated September 2 2002. The Companys status converted from a Private Limited Company to a Public Limited Company the name was changed from Rubicon Research Private Limited to Rubicon Research Limited. A fresh Certificate of Incorporation dated July 23 2024 was issued bythe Registrar of Companies Central Processing Centre Manesar Haryana consequent to Companys conversion into a Public Limited Company.Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research development and production of pharmaceutical products. The Company is driven by innovation through focused research and development with an increasing portfolio of specialty products and drugdevice combination products targeting regulated markets particularly the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016 the Company acquired majority stake by ECP III Pte Ltd. Further it acquired majority stake by General Atlantic Singapore RR Pte. Ltd. from ECP III Pte. Ltd. in 2019. In 2021 the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In 2024 the Company acquired Validus a New Jersey headquartered marketer of brand name formulation products in the US. Validus has twobrand name products in the CNS therapy area Equetro and Marplan. The Company is planning to raise money from public through IPO aggregating to Rs 1085 Crores consisting Rs 500 Crore Fresh Issue Equity Shares and an Offer for Sale of Rs 585 Crore Equity Shares..

Revenue: ₹534.34Cr as on June 2026 (Q1 FY27)
Net Profit: ₹84.78Cr as on June 2026 (Q1 FY27)
Listing date: 16 Oct, 2025
Chairperson Name: K G Ananthakrishnan
OrganisationRubicon Research Ltd
IndustryPharmaceuticals
CEOK G Ananthakrishnan
E-voting on sharesClick here to vote

FAQs

What is Rubicon Research share price today?

Rubicon Research share price today stands at ₹1776.7 as on . Rubicon Research share today touched a day high of ₹1812.3 and a low of ₹1712.1.

What is the 52 week high and 52 week low range for Rubicon Research share?

Rubicon Research touched a 52 week high of ₹1899 and a 52 week low of ₹570.75. Rubicon Research share price today i.e. is trending at ₹1776.7, which is -6.44% down from its 52 week high and 211.29% up from its 52 week low.

What is Rubicon Research's market capitalisation today?

Rubicon Research market capitalisation is ₹30,053.97 Cr as on .

How to buy Rubicon Research shares?

To buy Rubicon Research shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for RUBICON or Rubicon Research Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Rubicon Research shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Rubicon Research trading volume today?

Rubicon Research trading volume is 3.78L as on . This means that 3.78L shares of Rubicon Research were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Rubicon Research shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Rubicon Research have both increased over the past 30 days, and the average INDmoney investor holds the stock for 8 days. This reflects platform activity only and is not investment advice.